Two Sigma Investments
GYRE icon

Two Sigma Investments’s Gyre Therapeutics GYRE Stock Holding History

Two Sigma Investments’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,364
Closed -$41K – 2685
2022
Q1 		$41K Sell
8,364
-32,776
-80% -$162K ﹤0.01% 2501
2021
Q4 		$282K Buy
41,140
+33,931
+471% +$580K ﹤0.01% 3686
2021
Q3 		$222K Buy
7,209
+2,108
+41% +$69.4K ﹤0.01% 3890
2021
Q2 		$166K Sell
5,101
-23,508
-82% -$807K ﹤0.01% 3827
2021
Q1 		$1.08M Sell
28,609
-14,583
-34% -$667K ﹤0.01% 2238
2020
Q4 		$2.04M Sell
43,192
-3,312
-7% -$143K 0.01% 1479
2020
Q3 		$1.5M Buy
46,504
+4,008
+9% +$157K 0.01% 1484
2020
Q2 		$1.87M Buy
42,496
+14,855
+54% +$697K 0.01% 1135
2020
Q1 		$906K Sell
27,641
-2,737
-9% -$126K 0.01% 1483
2019
Q4 		$1.55M Buy
30,378
+16,647
+121% +$698K ﹤0.01% 1810
2019
Q3 		$506K Sell
13,731
-620
-4% -$33.4K ﹤0.01% 2551
2019
Q2 		$793K Buy
14,351
+1,169
+9% +$73.1K ﹤0.01% 2143
2019
Q1 		$802K Buy
13,182
+5,487
+71% +$353K ﹤0.01% 1961
2018
Q4 		$455K Sell
7,695
-18,418
-71% -$1.36M ﹤0.01% 2166
2018
Q3 		$2.11M Buy
26,113
+19,300
+283% +$1.53M 0.01% 1447
2018
Q2 		$596K Buy
6,813
+4,401
+182% +$772K ﹤0.01% 2530
2018
Q1 		$467K Buy
+2,412
New +$450K ﹤0.01% 2504
2015
Q1 		– Sell
-174
Closed -$361K – 2703
2014
Q4 		$361K Buy
174
+63
+57% +$121K ﹤0.01% 1862
2014
Q3 		$222K Buy
111
+7
+7% +$17.3K ﹤0.01% 1572
2014
Q2 		$371K Buy
104
+23
+28% +$75.1K ﹤0.01% 1749
2014
Q1 		$302K Sell
81
-67
-45% -$248K ﹤0.01% 1677
2013
Q4 		$484K Sell
148
-81
-35% -$319K ﹤0.01% 1675
2013
Q3 		$958K Buy
229
+38
+20% +$153K 0.01% 1033
2013
Q2 		$642K Buy
+191
New +$727K ﹤0.01% 1290

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Two Sigma Investments's GYRE Position: Q2 2022 in Review

Two Sigma Investments sold out of Gyre Therapeutics (GYRE) in Q2 2022, closing a stake of 8,364 shares — an estimated $41K sold.

Two Sigma Investments first reported a position in GYRE in Q2 2013 and held it in 24 quarters. The position peaked at $2.11M in Q3 2018. 41 funds tracked by Wall St. Rank hold GYRE as of Q2 2022.

  • Two Sigma Investments reported no remaining Gyre Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Investments sold 8,364 Gyre Therapeutics shares in Q2 2022, an estimated $41K.
  • Two Sigma Investments first reported a position in Gyre Therapeutics in Q2 2013 and held it in 24 quarters.
  • Two Sigma Investments's Gyre Therapeutics position peaked at $2.11M in Q3 2018.
  • 41 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.